Abstract: The present invention is directed to peptidomimetic macrocyclic compounds which inhibit prenyl-protein transferase and the prenylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting prenyl-protein transferase and the prenylation of the oncogene protein Ras.
Type:
Grant
Filed:
June 29, 1999
Date of Patent:
June 25, 2002
Assignee:
Merck & Co., Inc.
Inventors:
Christopher J. Dinsmore, Ian M. Bell, Douglas C. Beshore, Theresa M. Williams